A new review by George Washington University global health expert Nirbhay Kumar warns that eliminating malaria will require a strategic mix of interventions rather than reliance on a single tool, as cases and deaths rise and resistance threatens current prevention and treatment measures.
Rising burden and the limits of single solutions
The review, published in Trends in Parasitology, says an estimated 282 million malaria cases and about 610,000 deaths occurred in 2024 across 80 malaria-endemic countries. That represents an increase of roughly 9 million cases from the previous year, the paper reports.
Against this backdrop, the author argues that no single intervention will be universally effective. Instead, malaria programmes should deploy combinations of complementary tools that are chosen and timed according to local epidemiology and mosquito behaviour.
"No single magic bullet: the case for combined interventions for global malaria elimination and eradication," the review's title, encapsulates its central recommendation for multi-pronged, context-specific strategies.
Three pillars of a combined strategy
Kumar identifies three major categories of interventions that, when used together and tailored to local conditions, offer the strongest route toward long-term elimination:
- Mosquito control — insecticide-treated bed nets, indoor residual spraying and newer insecticides to reduce vector populations and prevent bites.
- Antimalarial drugs — combination treatments and chemoprevention to treat infections, reduce transmission and slow drug resistance.
- Vaccines — current vaccines provide a starting point for improved formulations, including combination vaccines that target different parasite species and life stages.
To illustrate how these elements can be organised, the review sets out a pragmatic framework for country-led decision-making based on real-time epidemiological and entomological data. The emphasis is on adaptive deployment so that regions with differing transmission patterns receive the most appropriate mix of tools.
| Intervention category | Purpose |
|---|---|
| Mosquito control | Reduce mosquito populations and prevent human–vector contact |
| Antimalarial drugs | Treat infection, provide preventive protection, mitigate resistance |
| Vaccines | Reduce disease burden and transmission; platform for future combination vaccines |
Local tailoring, equity and surveillance
The review cautions that there will be no universal combination that works everywhere. Malaria transmission dynamics vary substantially between regions — even within countries — and strategies must be informed by local entomological and epidemiological evidence.
Equity is a core concern: the paper calls for ensuring communities have fair access to vaccines, antimalarial medicines and next-generation vector-control technologies. It also stresses the need for strengthened surveillance systems to provide the real-time data necessary for targeted, timely responses.
For health services and policymakers, the implication is clear: investments should not favour a single shiny new product at the expense of maintaining and integrating proven measures. Instead, funding and operational planning should support a portfolio approach that can be adjusted as resistance patterns and transmission change.
Implications for South Africa and regional neighbours
Although the review addresses the global picture, its recommendations are directly relevant to malaria-endemic areas in southern Africa. National and provincial programmes should consider bolstering surveillance, expanding access to effective combinations of drugs and vector-control tools, and integrating vaccination where appropriate.
Clinics and health workers are reminded that while new tools are developing, early diagnosis and prompt, effective treatment remain critical. Members of the public with symptoms suggestive of malaria should seek assessment at a clinic or hospital rather than self-diagnosing or delaying care.
The review is a call to combine scientific advances with pragmatic, local decision-making to sustain gains and accelerate progress toward elimination. Strong surveillance, flexible programming and equitable access are central to that effort.
